---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-041802"
form_type: "8-K"
ticker: "MGRX"
cik: "0001938046"
company_name: "MANGOCEUTICALS, INC."
filed_at: "2024-10-21T23:59:59+00:00"
generated_at: "2026-05-30T12:32:31.390439+00:00"
event_type: "litigation"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# MangoRx faces Eli Lilly lawsuit over alleged copying of weight-loss drugs Zepbound/Mounjaro

## Summary
- Eli Lilly filed a lawsuit claiming MangoRx improperly copied its weight-loss medicines Zepbound and Mounjaro.
- MangoRx strongly refutes all claims regarding the sale of compounded tirzepatide and will vigorously defend.
- MangoRx provides access to compounded tirzepatide via its telemedicine platform for men's health and wellness.
- No financial details or specific damages claimed are disclosed in the filing.

## SEC filing metadata
- accession: 0001493152-24-041802
- form_type: 8-K
- ticker: MGRX
- cik: 0001938046
- company_name: MANGOCEUTICALS, INC.
- filed_at: 2024-10-21T23:59:59+00:00
- event_type: litigation
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1938046/000149315224041802/0001493152-24-041802-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1938046/000149315224041802/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-041802
- JSON: https://secwatch.observer/filing/0001493152-24-041802.json
- Plain text: https://secwatch.observer/filing/0001493152-24-041802.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.